JPH0256327B2 - - Google Patents
Info
- Publication number
- JPH0256327B2 JPH0256327B2 JP58008800A JP880083A JPH0256327B2 JP H0256327 B2 JPH0256327 B2 JP H0256327B2 JP 58008800 A JP58008800 A JP 58008800A JP 880083 A JP880083 A JP 880083A JP H0256327 B2 JPH0256327 B2 JP H0256327B2
- Authority
- JP
- Japan
- Prior art keywords
- drug
- present
- stage
- injection
- infarction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP880083A JPS59134722A (ja) | 1983-01-24 | 1983-01-24 | 出血性梗塞予防・治療剤 |
| EP84100760A EP0115331B1 (en) | 1983-01-24 | 1984-01-21 | Medicament for cerebral apoplexy |
| DE19843402058 DE3402058A1 (de) | 1983-01-24 | 1984-01-21 | Medikament gegen cerebrale apoplexie |
| DE8484100760T DE3461891D1 (de) | 1983-01-24 | 1984-01-21 | Medicament for cerebral apoplexy |
| CA000445863A CA1229793A (en) | 1983-01-24 | 1984-01-23 | Medicament for cerebral apoplexy |
| IT8467076A IT1214838B (it) | 1983-01-24 | 1984-01-24 | Farmaco per la terapia dell apoplessia cerebrale e composizione farmaceutica che lo contiene |
| US06/749,444 US4652581A (en) | 1983-01-24 | 1985-06-27 | Tetrahydroindole derivative as medicament for cerebral apoplexy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP880083A JPS59134722A (ja) | 1983-01-24 | 1983-01-24 | 出血性梗塞予防・治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59134722A JPS59134722A (ja) | 1984-08-02 |
| JPH0256327B2 true JPH0256327B2 (esLanguage) | 1990-11-29 |
Family
ID=11702927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP880083A Granted JPS59134722A (ja) | 1983-01-24 | 1983-01-24 | 出血性梗塞予防・治療剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59134722A (esLanguage) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0615228U (ja) * | 1992-07-23 | 1994-02-25 | 日本開閉器工業株式会社 | 表示機能付薄形スイッチ |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5015794A (esLanguage) * | 1973-06-14 | 1975-02-19 | ||
| JPS52156863A (en) * | 1976-06-23 | 1977-12-27 | Daicel Chem Ind Ltd | Preparation of 1-methyl-2,3,5,6-tetrahydro-3-hydroxy-5-semicarbazono-6-oxoindole |
-
1983
- 1983-01-24 JP JP880083A patent/JPS59134722A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0615228U (ja) * | 1992-07-23 | 1994-02-25 | 日本開閉器工業株式会社 | 表示機能付薄形スイッチ |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59134722A (ja) | 1984-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6244497B1 (ja) | 選択的s1p1レセプターアゴニストの投与法 | |
| JP2020186241A (ja) | 酸素化コレステロール硫酸塩(ocs)の使用 | |
| JP2010511701A (ja) | 水素化ピリド(4,3−b)インドール(異性体)に基づいた、発作を含む脳循環の急性および慢性疾患の治療のための手段、それに基づいた薬理学的手段、およびその使用のための方法 | |
| JP2015522630A (ja) | 多発性硬化症治療のためのビオチンの使用 | |
| US10016409B2 (en) | Method for improving interstitial flow | |
| JP2016074728A (ja) | 脱髄性および他の神経系疾患を患っている患者における神経認知的および/または神経精神医学的障害を改善するための4−アミノピリジンの使用 | |
| McCrystal et al. | Phase I study of the cytotoxic agent N-[2-(dimethylamino) ethyl] acridine-4-carboxamide | |
| KR20230010187A (ko) | 재개통 치료 후 재관류 손상 또는 출혈을 치료하기 위한 조성물 및 방법 | |
| US20070142266A1 (en) | Combination comprising a P-gp inhibitor and an anti-epileptic drug | |
| JP2000302798A (ja) | ジンセノサイドRb1からなる脳血管再生・再構築促進剤ならびに神経組織二次変性抑止剤 | |
| US4882336A (en) | Method and pharmaceutical composition for treating leukoencephalitic demyelinization clinical patterns of autoimmune origin, particularly multiple sclerosis | |
| JPH0256327B2 (esLanguage) | ||
| JPH01211522A (ja) | 梗塞および急性脳虚血の予防薬 | |
| WO2006117165A2 (en) | Means and methods for the treatment of head injuries and stroke | |
| JPH0369324B2 (esLanguage) | ||
| JP5837128B2 (ja) | カルボスチリルとカルニチンの組み合わせ医薬 | |
| WO2022199551A1 (en) | Dc009 for treating acute ischemic stroke | |
| JP4965791B2 (ja) | 敗血症性ショックの治療方法 | |
| WO2016047662A1 (ja) | 脳卒中の治療剤 | |
| CN120603579A (zh) | 新型溶液 | |
| JP2003504396A (ja) | マクロライド化合物の新規用途 | |
| JPH09227381A (ja) | 脳血栓における運動麻痺の改善剤 | |
| WO2026021478A1 (zh) | Ar降解剂与parp1抑制剂联合用于治疗前列腺癌的方法 | |
| FR2803522A1 (fr) | Nouvelle application therapeutique de l'enoxaparine | |
| CN115364100A (zh) | Ly2835219作为线粒体自噬诱导剂的用途 |